Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Driven by a cyclical rebound across overweight life sciences tools holdings, while initiating turnaround stakes in Biogen and Humana and exiting 14 positions.
Full Quick Take
Driven by a cyclical rebound across overweight life sciences tools holdings, while initiating turnaround stakes in Biogen and Humana and exiting 14 positions.
Underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin compression, while holding strong conviction in housing and core financial leaders.
Full Quick Take
Underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin compression, while holding strong conviction in housing and core financial leaders.
Dodge & Cox Stock Fund navigated Q2 2025 volatility by selectively adding to undervalued Health Care names like UnitedHealth while trimming recovering Financials. The portfolio trades at a low 14.2x forward earnings, representing a significant discount to the broader market.
Full Quick Take
Dodge & Cox Stock Fund navigated Q2 2025 volatility by selectively adding to undervalued Health Care names like UnitedHealth while trimming recovering Financials. The portfolio trades at a low 14.2x forward earnings, representing a significant discount to the broader market.